Z-0665-2017 Class II Terminated
FDA device recall Z-0665-2017 was initiated by Merge Healthcare, Inc. on Apr 30, 2014 and is designated Class II. Reason for recall: The application may crash during the cath lab procedure. The recall status is terminated (terminated Dec 23, 2019). Affected quantity: 192 sites potentially have the affected software.
Recall details
- Product Type
- Devices
- Report Date
- Dec 7, 2016
- Initiation Date
- Apr 30, 2014
- Termination Date
- Dec 23, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 192 sites potentially have the affected software
Product description
Merge Hemo software. Merge Hemo monitors, measures, and records physiologic data from a human patient undergoing a cardiac catheterization procedure. The Monitoring System is for the monitoring of vital parameters including ECG, SpO2, invasive blood pressure, temperature, NIBP and CO2, and for the evaluation of resting ECG, arrhythmias, ST-segments and cardiac output. Some systems are built and designed to measure End Tidal CO2. The system is intended for use in hospital cardiac catheterization laboratories
Reason for recall
The application may crash during the cath lab procedure.
Distribution pattern
Nationwide Distribution
Code information
Versions 9.10, 9.20.0, 9.20.2, 9.30.0, 9.40.0, 9.40.1, and 9.40.2 with Windows 7 Operating System
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0665-2017
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026